Fetal growth restriction may be the result of several possible conditions, including maternal, fetal and placental.
Q. A 34-year-old G1P0 is found to have a fetus with an estimated weight of 500 g infant at 28 weeks' gestation. Gestational dating had been confirmed by a first trimester ultrasound. How would you initially evaluate this patient?
A The definition of fetal growth restriction (FGR) is an estimated fetal weight (EFW) of less than the 10th percentile for gestational age.1 At 28 weeks' gestation, the 10th percentile for fetal weight is 720 g, so this fetus meets clinical criteria for FGR.2
FGR may be a result of several possible conditions, including maternal (eg, vascular disease), fetal (eg, aneuploidy, other genetic syndromes, infection), and placental (eg, insufficiency).3 This differential diagnosis should be considered at the time of diagnosis of FGR and reassessed subsequently at each visit based on the clinical picture. Determination of the etiology may help to guide clinical management.
A detailed ultrasound should focus on detection of fetal, umbilical cord, or placental anomalies. Fetal biometry should include measurements of the long bones. In addition to major congenital anomalies, the fetus should be assessed for ultrasound markers of fetal aneuploidy or fetal infection.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More